Søgeord (influenza) valgt.
27 emner vises.
1
Myndighederne følger udviklingen af fugleinfluenza nøje
Statens Serum Institut, 20.04.2024
Tilføjet 20.04.2024
Fugleinfluenzavirus fundet hos køer i USA har skabt opmærksomhed. Den danske myndighedsgruppe for Koordinering af Zoonoser (KOZO) følger situationen tæt.
Læs mere
2
Weekly respiratory virus update, week 14, April 2024
ECDC
ECDC COVID-19 updates, 15.04.2024
Tilføjet 15.04.2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels.
Læs mere
3
Communicable disease threats report, 7 - 13 April 2024, week 15
ECDC
ECDC COVID-19 updates, 12.04.2024
Tilføjet 12.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Læs mere
4
Communicable disease threats report, 7 - 13 April 2024, week 15
ECDC
ECDC Communicable Disease Threats Report, 12.04.2024
Tilføjet 12.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Læs mere
5
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Sarah K Nørgaard, Jens Nielsen, Anne Christine Nordholm, Lukas Richter, Alena Chalupka, Natalia Bustos Sierra, Toon Braeye, Maria Athanasiadou, Theodore Lytras, Gleb Denissov, Oskari Luomala, Anne Fouillet, Isabelle Pontais, Matthias an der Heiden, Benedikt Zacher, Alina Weigel, Ivo Foppa, Kassiani Gkolfinopoulou, Ioannis Panagoulias, Anna Paldy, Tibor Malnasi, Lisa Domegan, Eva Kelly, Naama Rotem, Oksana Rakhlin, Francesca K de'Donato, Chiara Di Blasi, Patrick Hoffmann, Telma Velez, Kathleen England, Neville Calleja, Liselotte van Asten, Femke Jongenotter, Ana Paula Rodrigues, Susana Silva, Petra Klepac, Diana Gomez-Barroso, Inmaculada Leon Gomez, Ilias Galanis, Ahmed Farah, Rolf Weitkunat, Katarina Fehst, Nick Andrews, Tom Clare, Declan T Bradley, Mark G O'Doherty, Naoma William, Mark Hamilton, Bolette Søborg, Tyra G Krause, Nick Bundle and Lasse S Vestergaard
Eurosurveillance latest updates, 12.04.2024
Tilføjet 12.04.2024
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
Læs mere
6
CDC Issues Health Alert for Bird Flu Infection in US
Medscape Infectious Diseases, 8.04.2024
Tilføjet 8.04.2024
The U.S. CDC on Friday issued a health alert to inform clinicians, state health departments and the public of a case of avian influenza in a person who had contact with... Reuters Health Information
Læs mere
7
Weekly respiratory virus update, week 13, April 2024
ECDC
ECDC COVID-19 updates, 8.04.2024
Tilføjet 8.04.2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels.
Læs mere
8
European Scientists Assess Avian Flu Pandemic Risk
Medscape Infectious Diseases, 6.04.2024
Tilføjet 6.04.2024
The risk for widespread infection for humans from avian influenza remains low in Europe, but health authorities have urged enhanced vigilance and biosecurity measures. Medscape Medical News
Læs mere
9
Communicable disease threats report, 31 March - 6 April 2024, week 14
ECDC
ECDC COVID-19 updates, 5.04.2024
Tilføjet 5.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 March - 6 April 2024 and includes updates on SARS-CoV-2, cholera, avian influenza A(H5N1), swine influenza A(H1N2) and Middle East respiratory syndrome coronavirus (MERS-CoV).
Læs mere
10
Communicable disease threats report, 31 March - 6 April 2024, week 14
ECDC
ECDC Communicable Disease Threats Report, 5.04.2024
Tilføjet 5.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 March - 6 April 2024 and includes updates on SARS-CoV-2, cholera, avian influenza A(H5N1), swine influenza A(H1N2) and Middle East respiratory syndrome coronavirus (MERS-CoV).
Læs mere
11
Fugleinfluenzavirus fundet i køer i USA
Statens Serum Institut, 5.04.2024
Tilføjet 5.04.2024
Flere amerikanske malkekvægsbesætninger er testet positive for fugleinfluenzavirus, det er usædvanligt at køer smittes med denne form for virus. Dansk Veterinær Konsortium (DK-VET) følger udviklingen nøje.
Læs mere
12
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, Lisa Domegan, Clara Mazagatos, Silke Buda, Adam Meijer, Irina Kislaya, Catalina Pascu, AnnaSara Carnahan, Beatrix Oroszi, Maja Ilić, Marine Maurel, Aryse Melo, Virginia Sandonis Martín, Camino Trobajo-Sanmartín, Vincent Enouf, Adele McKenna, Gloria Pérez-Gimeno, Luise Goerlitz, Marit de Lange, Ana Paula Rodrigues, Mihaela Lazar, Neus Latorre-Margalef, Gergő Túri, Jesús Castilla, Alessandra Falchi, Charlene Bennett, Virtudes Gallardo, Ralf Dürrwald, Dirk Eggink, Raquel Guiomar, Rodica Popescu, Maximilian Riess, Judit Krisztina Horváth, Itziar Casado, Mª del Carmen García, Mariëtte Hooiveld, Ausenda Machado, Sabrina Bacci, Marlena Kaczmarek, Esther Kissling and on behalf of the European Primary Care Vaccine Effectiveness Group
Eurosurveillance latest updates, 29.03.2024
Tilføjet 29.03.2024
BackgroundScarce European data in early 2021 suggested lower vaccine effectiveness (VE) against SARS-CoV-2 Omicron lineages than previous variants. AimWe aimed to estimate primary series (PS) and first booster VE against symptomatic BA.1/BA.2 infection and investigate potential biases. MethodsThis European test-negative multicentre study tested primary care patients with acute respiratory symptoms for SARS-CoV-2 in the BA.1/BA.2-dominant period. We estimated PS and booster VE among adults and adolescents (PS only) for all products combined and for Comirnaty alone, by time since vaccination, age and chronic condition. We investigated potential bias due to correlation between COVID-19 and influenza vaccination and explored effect modification and confounding by prior SARS-CoV-2 infection. ResultsAmong adults, PS VE was 37% (95% CI: 24–47%) overall and 60% (95% CI: 44–72%), 43% (95% CI: 26–55%) and 29% (95% CI: 13–43%)
Læs mere
13
Digital Nudges Found to Be Duds in Flu Vax Trial
Medscape Infectious Diseases, 28.03.2024
Tilføjet 28.03.2024
Reminders sent via text message or patient portal did not increase rates of influenza vaccination. Medscape Medical News
Læs mere
14
Communicable disease threats report, 24-30 March 2024, week 13
ECDC
ECDC Communicable Disease Threats Report, 27.03.2024
Tilføjet 27.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 24-30 March 2024 and includes updates on cholera and influenza A(H5N1).
Læs mere
15
Severe Flu Confers Higher Risk for Neuro Disorders vs COVID
Medscape Infectious Diseases, 22.03.2024
Tilføjet 22.03.2024
Hospitalization for influenza raises the risk for future neurologic conditions more than hospitalization for COVID-19, the results of a large study showed. Medscape Medical News
Læs mere
16
Reporting Protocol for integrated respiratory virus surveillance, version 1.5
ECDC
ECDC COVID-19 updates, 20.03.2024
Tilføjet 20.03.2024
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
Læs mere
17
Communicable disease threats report, 10-16 March 2024, week 11
ECDC
ECDC COVID-19 updates, 15.03.2024
Tilføjet 15.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 March 2024 and includes updates on SARS-CoV-2 variant classification, avian influenza, measles, cholera, and overview of respiratory virus epidemiology in the EU/EE.
Læs mere
18
Communicable disease threats report, 10-16 March 2024, week 11
ECDC
ECDC Communicable Disease Threats Report, 15.03.2024
Tilføjet 15.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 March 2024 and includes updates on SARS-CoV-2 variant classification, avian influenza, measles, cholera, and overview of respiratory virus epidemiology in the EU/EE.
Læs mere
19
Communicable disease threats report, 25 February - 2 March 2024, week 9
ECDC
ECDC COVID-19 updates, 2.03.2024
Tilføjet 2.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 25 February - 2 March 2024, and includes updates on on cholera, avian influenza, SARS-CoV-2 variant classification, and an overview of respiratory virus epidemiology in the EU/EEA.
Læs mere
20
Communicable disease threats report, 25 February - 2 March 2024, week 9
ECDC
ECDC Communicable Disease Threats Report, 1.03.2024
Tilføjet 1.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 25 February - 2 March 2024, and includes updates on on cholera, avian influenza, SARS-CoV-2 variant classification, and an overview of respiratory virus epidemiology in the EU/EEA.
Læs mere
21
Does an October Birthday Protect Kids From Flu?
Medscape Infectious Diseases, 1.03.2024
Tilføjet 1.03.2024
New research showed that children born in October may have lower rates of influenza diagnosis. Medscape Medical News
Læs mere
22
Effectiveness of interventions to increase healthcare workers’ adherence to vaccination against vaccine-preventable diseases: a systematic review and meta-analysis, 1993 to 2022
Marco Clari, Beatrice Albanesi, Rosanna Irene Comoretto, Alessio Conti, Erika Renzi, Michela Luciani, Davide Ausili, Azzurra Massimi and Valerio Dimonte
Eurosurveillance latest updates, 1.03.2024
Tilføjet 1.03.2024
BackgroundVaccination adherence among healthcare workers (HCWs) is fundamental for the prevention of vaccine-preventable diseases (VPDs) in healthcare. This safeguards HCWs\' well-being, prevents transmission of infections to vulnerable patients and contributes to public health. AimThis systematic review and meta-analysis aimed to describe interventions meant to increase HCWs’ adherence to vaccination and estimate the effectiveness of these interventions. MethodsWe searched literature in eight databases and performed manual searches in relevant journals and the reference lists of retrieved articles. The study population included any HCW with potential occupational exposure to VPDs. We included experimental and quasi-experimental studies presenting interventions aimed at increasing HCWs’ adherence to vaccination against VPDs. The post-intervention vaccination adherence rate was set as the main outcome. We included the effect of interventions in the random-effects and subgroup meta-analyses. ResultsThe systematic review considered 48 studies on influenza and Tdap vaccination from database and manual searches, and 43 were meta-analysed. A statistically significant, positive effect was seen in multi-component interventions in randomised controlled trials (relative risk (RR) = 1.37; 95% CI: 1.13–1.66) and in observational studies (RR = 1.43; 95% CI: 1.29–1.58). Vaccination adherence rate was higher in community care facilities (RR = 1.58; 95% CI: 1.49–1.68) than in hospitals (RR = 1.24; 95% CI: 0.76-2.05). ConclusionInterventions aimed at increasing HCWs’ adherence to vaccination against VPDs are effective, especially multi-component ones. Future research should determine the most effective framework of interventions for each setting, using appropriate study design for their evaluation, and should compare intervention components to understand their contribution to the effectiveness.
Læs mere
23
Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024
Morbidity and Mortality Weekly Report (MMWR), 29.02.2024
Tilføjet 29.02.2024
This report describes estimated vaccine effectiveness for laboratory-confirmed flu in California.
Læs mere
24
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States
Morbidity and Mortality Weekly Report (MMWR), 29.02.2024
Tilføjet 29.02.2024
This report describes estimates of 2023-24 influenza vaccine effectiveness among different age groups.
Læs mere
25
Communicable disease threats report, 18-24 February 2024, week 8
ECDC
ECDC COVID-19 updates, 24.02.2024
Tilføjet 24.02.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 18-24 February 2024 and includes updates on influenza, poliomyelitis, SARS-CoV-2, and an overview of respiratory virus epidemiology in the EU/EEA.
Læs mere
26
Communicable disease threats report, 18-24 February 2024, week 8
ECDC
ECDC Communicable Disease Threats Report, 23.02.2024
Tilføjet 23.02.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 18-24 February 2024 and includes updates on influenza, poliomyelitis, SARS-CoV-2, and an overview of respiratory virus epidemiology in the EU/EEA.
Læs mere
27
Europe Greenlights Two Avian Flu Vaccines
Medscape Infectious Diseases, 23.02.2024
Tilføjet 23.02.2024
The vaccines, Celldemic and Incellipan, protect against the H5N1 subtype of the influenza A virus. Medscape Medical News
Læs mere